title: Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
authors.forename: K
authors.initials: K
authors.lastname: Rave
authors.forename: L
authors.initials: L
authors.lastname: Heinemann
authors.forename: L
authors.initials: L
authors.lastname: Puhl
authors.forename: U
authors.initials: U
authors.lastname: Gudat
authors.forename: J R
authors.initials: JR
authors.lastname: Woodworth
authors.forename: C
authors.initials: C
authors.lastname: Weyer
authors.forename: T
authors.initials: T
authors.lastname: Heise
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002626:Chemistry, Pharmaceutical; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061268:Insulin Lispro; D007336:Insulin, Isophane / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D007336:Insulin, Isophane